Conclusions
Our review has demonstrated a non-significant rise in the frequency of
IUD in the pandemic period in 2020 compared to those in 2019.
Additionally, there was a significantly lower lymphocyte count during
the pandemic period- a marker known to be associated with COVID-19. This
acts as proof of concept and warrants ongoing investigation to explore
the link between COVID-19 and disorders of poor placental perfusion,
particularly the rates of IUD.